Omnipaque Shortage


As we know, Omnipaque has been in short supply due to a temporary Covid related shut down of its manufacturing plant in China. Normal production has resumed, however due to re-stocking of supply, some Omnipaque doses will be slightly more difficult to obtain until December 2022. Click here to see if when you can expect to see your preferred dose back in normal supply.


Please remember Omnipaque is a Single Dose Vial. The vials cannot be used for multiple patients, unless divided underneath an approved laminar flow hood. Please read more by clicking here.


The specific risk of infection was mentioned in this 2012 article.


References:

  1. https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=830&loginreturnUrl=SSOCheckOnly

  2. https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Iohexol+Injection&st=c&tab=tabs-3&i=11&panel=11


1 view0 comments

Recent Posts

See All